Diabetes reversal company Breathe Well-being raises pre-Series B round

Diabetes reversal company Breathe Well-being has raised Rs 50 crore in a pre-Series B round co-led by 3One4 Capital, Accel and General Catalyst. The round also saw participation of FounderBank Capital and Supermorpheus.

The company plans to utilise the raised funds to strengthen its coaching academy, expand the core team, and scale up the technology platform to enhance customer experience, Breathe Well-being said in a press statement.

Founded in 2020 by Rohan Verma and Aditya Kaicker, Breathe Well-being offers an alternative to medicines to prevent, manage and reverse Type 2 Diabetes. Breathe Well-being’s clinically proven digital program uses a personalised coach driven, community first approach through interactive gamification to help people with Type 2 diabetes reduce HbA1c, lose weight and reduce medication dependability.

Clinically proven diabetes reversal program by Breathe helps reduce HbA1c levels, lose weight, improve glucose tolerance and stop diabetes medication eventually. Breathe Well-being says that its program has a proven outcome with over 95% participants showing an average reduction of 1.5% in their HbA1c levels. Over 98% participants eliminating medication and experienced an average weight loss of 5.5 Kg over the course of the program which has been recognised by the American Diabetes Association (ADA).

According to the Gurugram-based company, it is rapidly expanding across product, growth, technology and analytics. It also claims to help 70 million Indians to prevent, manage and reverse Type 2 diabetes.